Bank of America’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-310
Closed -$23.2K 8530
2025
Q2
$23.2K Sell
310
-1,190
-79% -$105K ﹤0.01% 7026
2025
Q1
$141K Buy
+1,500
New +$110K ﹤0.01% 6338
2024
Q3
Sell
-26
Closed -$1.93K 8306
2024
Q2
$1.93K Sell
26
-54,799
-100% -$4.63M ﹤0.01% 7149
2024
Q1
$4M Buy
+54,825
New +$4.57M ﹤0.01% 3830
2023
Q3
Sell
-1,004
Closed -$144K 7864
2023
Q2
$144K Buy
1,004
+834
+491% +$125K ﹤0.01% 6037
2023
Q1
$35K Buy
170
+146
+608% +$24.8K ﹤0.01% 6604
2022
Q4
$4.05K Sell
24
-251
-91% -$51.4K ﹤0.01% 7099
2022
Q3
$66K Sell
275
-38
-12% -$8.83K ﹤0.01% 6552
2022
Q2
$122K Sell
313
-1,927
-86% -$966K ﹤0.01% 6374
2022
Q1
$786K Buy
2,240
+604
+37% +$237K ﹤0.01% 5458
2021
Q4
$421K Buy
1,636
+1,137
+228% +$261K ﹤0.01% 6020
2021
Q3
$106K Buy
499
+211
+73% +$44.9K ﹤0.01% 6690
2021
Q2
$56K Buy
+288
New +$64.6K ﹤0.01% 6778
2020
Q4
Sell
-923
Closed -$551K 7232
2020
Q3
$551K Buy
923
+882
+2,151% +$569K ﹤0.01% 4640
2020
Q2
$28K Buy
+41
New +$51.5K ﹤0.01% 6176

Other funds holding LABD

Bank of America's LABD Position: Q3 2025 in Review

Bank of America sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2025, closing a stake of 310 shares — an estimated $23.2K sold.

Bank of America first reported a position in LABD in Q2 2020 and held it in 15 quarters. The position peaked at $4M in Q1 2024. 18 funds tracked by Wall St. Rank hold LABD as of Q3 2025.

  • Bank of America reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 310 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2025, an estimated $23.2K.
  • Bank of America first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2020 and held it in 15 quarters.
  • Bank of America's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $4M in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.